SCHEMBL6490170

SCHEMBL6490170

Cc1nc(-c2ccc(C(F)(F)F)cc2)sc1Cn1c(C)nc2c(C)cc(OCCCC(=O)O)cc21

nearest known ligand 0.55

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 18/20 0.55
PPARA Q07869 14/20 0.55
PPARG P37231 10/20 0.55
FFAR1 O14842 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6489283 0.91 PPARD (0.47) PPARDPPARAPPARGFFAR1
SCHEMBL6491782 0.91 PPARD (0.52) PPARDPPARAPPARGFFAR1
SCHEMBL6487860 0.84 PPARD (0.46) PPARDPPARAPPARGFFAR1
SCHEMBL6491177 0.80 PPARD (0.40) PPARDPPARAPPARGFFAR1
SCHEMBL6502085 0.78 NR1H4 (0.49) PPARDPPARAPPARGFFAR1
SCHEMBL6497809 0.76 MCL1 (0.41) FFAR1
SCHEMBL6491350 0.76 MAPT (0.44) PPARDPPARAPPARG
SCHEMBL5654322 0.75 PPARD (0.81) PPARDPPARAPPARGFFAR1
SCHEMBL6614634 0.74 PPARD (0.85) PPARDPPARAPPARGFFAR1
SCHEMBL6488835 0.73 MCL1 (0.42) PPARDPPARAPPARGFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD PPARD 290/4885PPARA 665/4885PPARG 233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.